Nivolumab plus ipilimumab immunotherapy-related irAEs

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2035卷 / 1期
关键词：
D O I：
10.1007/s40278-024-70759-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 9
相关论文
共 50 条
  • [41] Nivolumab (Opdivo) plus Ipilimumab (Yervoy) for Metastatic Melanoma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1483): : 168 - 168
  • [42] Imaging Findings in Immunotherapy-related Renal Toxicity
    Khauli, Mark A.
    An, Thomas J.
    Anderson, Mark A.
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (03) : 162 - 166
  • [43] DIRMC: a database of immunotherapy-related molecular characteristics
    Liu, Yue
    Zhou, Yuhuan
    Hu, Xiumei
    Le-Ge, Wuri
    Wang, Haoyan
    Jiang, Tao
    Li, Junyi
    Hu, Yang
    Wang, Yadong
    DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION, 2024, 2024
  • [44] Liver macrophages and neutrophils in immunotherapy-related toxicity
    Jordan Hindson
    Nature Reviews Gastroenterology & Hepatology, 2021, 18 : 593 - 593
  • [45] IMMUNOTHERAPY-RELATED GASTRITIS IN A TERTIARY ONCOLOGY CENTRE
    Cheung, Vincent
    Gupta, Tarun
    Ye, Weiyu
    Middleton, Mark
    Fairfax, Ben
    Payne, Miranda
    Brain, Oliver
    GUT, 2019, 68 : A147 - A148
  • [46] Management of Immunotherapy-Related Toxicities, Version 1.2022
    Thompson, John A.
    Schneider, Bryan J.
    Brahmer, Julie
    Achufusi, Amaka
    Armand, Philippe
    Berkenstock, Meghan K.
    Bhatia, Shailender
    Budde, Lihua E.
    Chokshi, Saurin
    Davies, Marianne
    Elshoury, Amro
    Gesthalter, Yaron
    Hegde, Aparna
    Jain, Michael
    Kaffenberger, Benjamin H.
    Lechner, Melissa G.
    Li, Tianhong
    Marr, Alissa
    McGettigan, Suzanne
    McPherson, Jordan
    Medina, Theresa
    Mohindra, Nisha A.
    Olszanski, Anthony J.
    Oluwole, Olalekan
    Patel, Sandip P.
    Patil, Pradnya
    Reddy, Sunil
    Ryder, Mabel
    Santomasso, Bianca
    Shofer, Scott
    Sosman, Jeffrey A.
    Wang, Yinghong
    Zaha, Vlad G.
    Lyons, Megan
    Dwyer, Mary
    Hang, Lisa
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (04): : 387 - 405
  • [47] Liver macrophages and neutrophils in immunotherapy-related toxicity
    Hindson, Jordan
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2021, 18 (09) : 593 - 593
  • [48] Immunotherapy-related cutaneous AEs respond to treatments
    Reactions Weekly, 2019, 1760 (1) : 8 - 8
  • [49] The predictive biomarker for immune-related adverse events (irAEs) in patients with metastatic renal cell carcinoma treated with the combination therapy of nivolumab plus ipilimumab: Musashino study-irAE
    Kizawa, R.
    Kuno, M.
    Washino, S.
    Shirotake, S.
    Izumi, K.
    Inoue, M.
    Kagawa, M.
    Takeshita, H.
    Hyodo, Y.
    Kawakami, S.
    Saito, K.
    Kageyama, Y.
    Oyama, M.
    Miyagawa, T.
    Miura, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1488 - S1488
  • [50] Current Standard in Monitoring of Immunotherapy-Related Toxicity
    Mathias, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1658 - S1659
12345